Summary.-Groups of 4 guinea-pigs were immunized with acid extracts prepared from bovine myelin (EF), normal human liver tissue and malignant or benign neoplastic tissues in Freund's complete adjuvant (FCA). The I.d. skin testing was shown to be most consistent in demonstrating positive delayed hypersensitivity, whilst the MMI test frequently gave negative results in the presence of pronounced skin responses to specific extracts. Thus it was shown that 3/4 animals immunized with basic proteins extracted from an adenocarcinoma of the lung or related hepatic metastases, and 1/2 animals immunized with an extract of a carcinoma of the breast, gave intense erythema and induration responses 5 mm in diameter 24 h after i.d. challenge with EF. No such response was obtained in animals immunized with basic proteins extracted from normal human liver, any of the other neoplastic tissues, or in control animals immunized with FCA only.
THE INDUCTION of experimental allergic encephalomyelitis (EAE) in a variety of animal species by immunization with a basic myelin protein termed encephalitogenic factor (EF) has been well documented (Alvord, 1968; Eylar & Thompson, 1969) and is taken by many workers as an experimental model of multiple sclerosis (Paterson, 1969) . The aetiology of EAE is presumptively of an autoimmune nature, immunization with EF in Freund's complete adjuvant (FCA) generating a clone of lymphocytes capable of damaging the myelin sheath through recognition and interaction with the EF molecule located in the intraperiod line of lamellar myelin (Dickinson et al., 1970) .
Studies of cell-mediated immunity have shown that lymph-node cells from animals with EAE respond to EF, as demonstrated by lymphokine production or blast transformation (Lennon et al., 1970; Coates & Carnegie, 1975) , further supporting a possible autoimmune aetiology. Moreover, Field & Caspary (1970) showed that lymphocytes taken from cancer patients responded to EF in the macrophage electrophoretic mobility (MEM) test, an assay which reputedly detects cell-mediated immunity. Subsequently these findings have been confirmed (Pritchard et al., 1972; Goldstone et al., 1973) . However, the demonstration of a lymphocyte response to EF with the MEM test in cancer patients is not entirely unequivocal, and reports have appeared recently which fail to confirm the original findings (Arvilommi et al., 1977; Forrester et al., 1977) . However, the more conventional and widely accepted macrophage migration inhibition (MMI) test has been successfully applied to the detection ofdelayed hypersensitivity responses to EF in cancer patients (Light et al., 1 975; Shelton et al., 1975; Flavell & Potter, 1978) though the observed incidence of detectable lymphocyte sensitivity seen in these studies is somewhat lower than for those reported for the MEM assay.
Using the MEM test, Caspary & Field (1971) demonstrated that lymphocytes from cancer patients also responded to basic proteins extracted from a variety of human malignant tumours, termed cancer basic protein (CaBP), and concluded that the lymphocyte response to EF seen in cancer patients represented immunological cross-reactivity between EF and neoantigen(s) appearing on the tumour-cell surface. Further studies have shown that EF and basic malignanttissue proteins are physico-chemically very similar (Dickinson & Caspary, 1973) and share common antigenic determinant(s) (Coates & Carnegie, 1975; McDermott et al., 1974) . However, whilst the intact EF molecule has been shown to be potently encephalitogenic for a variety of animal species, to the best of our knowledge basic malignant-tissue proteins have not been shown to be so.
In the present study we report on the protein compositions, as determined by polyacrylamide-gel electrophoresis, of a variety of acid extracts prepared from neoplastic tissues, normal human liver tissue and bovine myelin (EF) and tentatively demonstrate immunological crossreactivity between bovine EF and 2 of the tumour extracts in immunized animals by i.d. skin-testing and migration inhibition studies. Moreover, animals immunized with tumour extracts and showing immunological cross-reactivity with EF developed lesions in the cerebral cortex superficially resembling those seen in EAE.
MATERIALS AND METHODS
Tissue extracts. Bovine encephalitogenic factor (EF) and cancer basic proteins (CaBP) w%Aere prepared according to the method of Dr J. P. Dickinson (personal communication) .
Bovine brains were obtained from the local slaughterhouse and processing began within 45 min of the death of the animal. The preparation of the EF has been outlined elsewhere (Flavell & Potter, 1978 ley) 12 days after the initial immunization. Animals were killed at the 21st day by decapitation under deep ether anaesthesia and PEC collected and processed as described previously (Rees & Potter, 1973) . The MMI test was set up exactly as described previously Table II .
Generally, though not invariably, animals immunized with a specific tumour extract exhibited delayed-type skin responses of > 5 mm 24 h after i.d. challenge, to all the other extracts with the exception of bovine EF. On the contrary, the MMI test frequently gave negative results even in the presence of intense delayed skin responses to the same extract. Thus, 4/4 animals immunized with Extract la (adenocarcinoma of lung) gave intense skin responses 24 h after challenge with the autologous extract, whilst MMI at a significance level of P < 0 01 was detected in only 2 of these animals (Table II) . Similarly, of 4 animals immunized with Extract la, 2 gave positive skin responses to Extracts 3 (carcinoma of breast) and 4 (adenocarcinoma of endometrium) and 3 to Extract 7 (normal human liver), whilst the same extracts did not mediate significant MMI in the same animals (Table II) .
Positive However, if the effects that we have observed in the present study are due to a componentr or components produced by the tumour and not to nervous-trissue contaminants, this might indicate anl important aetiological mechanism in certain types of carcinomatous neuropathy, particularly the encephalomyelitic forms (Henson et al., 1965) . Thus, the appearance of neoantigen(s) on the surface of certain tumour cell types, structur ally similar to a nervous-tissue component or components, and possibly an encephalitogenic (leterminant of the EF molectule (Chao & Einstein, 1970; Swanborg, 1970) may initiate an autoimmune response directed against nervouis tissues. Thus, the de-(generation and demyelination of sural nerves from cancer patients has been noted previouisly by Schlaepfer (1974) and histopathological examination of nervous tissue from patients with carcinomatous sensory neuropathy frequiently reveals the presence of encephalomyelitis (Henson et al., 1965) above what might be expected of a nonspecific reactive process to tissue breakdown. It is also interesting to note that the tumour extracts which in the present studv possessed mild encephalitogenic properties and also showed immunological cross-reactivitv with EF were derived from a lung carcinoma, a tuimour type associated with the highest incidence of neurological abnormalities in cancer patients (Dayan et al., 1965-; Brain & Henson, 1958) The original objective of this study was to investigate immunological cross-reactivity between basic proteins extracted from neoplastic tissues and EF, in an attempt to explain the observed lymphocyte response to EF seen in the majority of cancer patients in the macrophage electrophoretic mobility (MEM) test (Caspary & Field, 1]971; Goldstone et al., 1973; Pritchard et al., 1972) and macrophage migration inhibition (MMI) test (Shelton et al., 1975; Light et al., 1975; Flavell & Potter, 1978 
